66 results
8-K
AXLA
Axcella Health Inc.
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
, following the Board Resignations, it is the Staff’s belief that the Company is no longer in compliance with the majority independent board requirement under
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
, or bylaws, provide that a majority of the shares entitled to vote, present in person or represented by proxy, will constitute a quorum for the transaction … is obtained.
How is the vote counted?
Under our bylaws, any proposal other than an election of directors is decided by a majority of the votes properly cast
8-K
EX-99.1
opcv ghvwcxls05olh
30 Mar 23
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:22am
8-K
EX-10.1
qgl630m1 uz
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
evfsrx2e9s2a hl3ml
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
apn6bdg7
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
bvkuuh
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
8-K
EX-10.1
03fd1dlww6
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
nmk6qd 51ii6vmpso47
16 Mar 22
Prospectus supplement for primary offering
8:00am